1. Clinical

Access Denied

Written by Posted on Less than 0 min read


Access Denied

You don’t have permission to access ” on this server.

Reference #18.daad617.1727136746.2c66077

Member since

More from Admin

  1. Clinical

Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Sufferers with LVADs, RVADs, Biventricular Help Gadgets, and Whole Synthetic Hearts

PONTE VEDRA, Fla., April 9, 2024 — Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical firm growing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to forestall coronary heart assaults, strokes, and deaths as a consequence of blood clots in sufferers with uncommon cardiovascular circumstances, introduced immediately that the USA Meals and Drug […]
Written by
  1. Clinical

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor

CAMBRIDGE Mass. – July 24, 2024 – Sage Therapeutics, Inc. (NASDAQ: Sage) and Biogen Inc. (NASDAQ: BIIB) announced topline results from the Phase 2 KINETIC 2 dose-range study of the oral investigational drug SAGE-324 (BIIB124) as a potential treatment in essential tremor (ET). The KINETIC 2 Study did not demonstrate a statistically significant dose-response relationship […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Phase 2 Spring Trial Of LHP588, Treatment For P. Gingivalis-positive Alzheimer’s Disease Proceeds

SAN FRANCISCO, Nov. 16, 2023. Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of Alzheimer’s and other diseases of aging, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for LHP588, the company’s next-generation gingipain inhibitor, for the treatment of P. gingivalis-positive […]
Written by
  1. Clinical

Unlocking the Potential of Clinical Trials for Improved Patient Outcomes

Clinical trials play a crucial role in enhancing patient outcomes and driving advancements in medical research. By unlocking the potential of clinical trials, we can gather important data, develop innovative therapies, and improve the overall quality of patient care. Clinical trials are essential in evaluating the safety and effectiveness of new treatments, drugs, and procedures. […]
Written by
  1. Clinical

AbbVie Announces Positive Topline Results from Phase 2 Trial Evaluating Elahere for High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer

NORTH CHICAGO, Ill., June 6, 2024. AbbVie announced today positive topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab soravtansine (ELAHERE) monotherapy in heavily pre-treated patients with folate receptor-alpha (FRα) positive, platinum-sensitive ovarian cancer (PSOC). The study met its primary endpoint with an objective response rate (ORR) of 51.9% (95%CI 40.4 – 63.3%). […]
Written by
  1. Clinical

Lisata Therapeutics Pronounces U.S. FDA Uncommon Pediatric Illness Designation Granted to LSTA1 for the Therapy of Osteosarcoma

BASKING RIDGE, N.J., March 21, 2024. Lisata Therapeutics, Inc. (“Lisata” or the “Firm”), a clinical-stage pharmaceutical firm growing progressive therapies for the remedy of superior strong tumors and different severe illnesses, at present introduced that the U.S. Meals and Drug Administration (the “FDA”) has granted Uncommon Pediatric Illness Designation (“RPDD”) to LSTA1, the Firm’s lead […]
Written by
  1. Clinical

Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV

HAYWARD, Calif., May 30, 2024. Avirmax Biopharma, Inc., a leading innovator in genetic medicines, is pleased to announce that it has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration (AMD) including Polypoidal […]
Written by
  1. Clinical

FDA Clears Investigational New Drug application for muscular dystrophy treatment

MINNEAPOLIS and ST. PAUL, Minn., July 17, 2024. Today, Myogenica, a University of Minnesota startup company, announced U.S. Food and Drug Administration approval for an Investigational New Drug (IND) application for MyoPAXon — an induced pluripotent stem cell-derived muscle stem cell product to regenerate skeletal muscle. A pending clinical trial would evaluate the safety, tolerability […]
Written by
  1. Clinical

Decrease Dose of Mpox Vaccine is Secure and Generates Six-Week Antibody Response Equal to Commonplace Routine

April 27, 2024 — A dose-sparing intradermal mpox vaccination routine was protected and generated an antibody response equal to that induced by the usual routine at six weeks (two weeks after the second dose), based on findings offered immediately on the European Society of Scientific Microbiology and Infectious Ailments World Congress in Barcelona. The outcomes […]
Written by
  1. Clinical

First-Affected person Dosed in Part 2 Scientific Examine Evaluating NBI-1070770 in Adults with Main Depressive Dysfunction

SAN DIEGO, April 3, 2024. Neurocrine Biosciences, Inc. right this moment introduced that the primary affected person has been randomized for its Part 2 scientific research to judge the efficacy, security, and tolerability of investigational compound NBI-1070770 in adults with main depressive dysfunction. NBI-1070770 is a novel, selective, and orally energetic, unfavorable allosteric modulator (NAM) […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

As human activities expand in Antarctica, scientists identify crucial conservation sites

A team of scientists led by the University of Colorado Boulder has identified 30 new areas critical for conserving biodiversity in the Southern Ocean surrounding Antarctica. In a study published Aug. 15 in the journal Conservation Biology, the researchers warn that without greater protection to limit human activities in these areas, native wildlife could face […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Boosting biodiversity without hurting local economies

Protected areas, like nature reserves, can conserve biodiversity without harming local economic growth, countering a common belief that conservation restricts development. A new study outlines what is needed for conservation to benefit both nature and people. Conservation zones aim to preserve biodiversity, protect endangered species, and maintain natural habitats. “There’s long been uncertainty about the […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

An exotic tick that can kill cattle is spreading across Ohio

A species of exotic tick arrived in Ohio in 2021 in such huge numbers that their feeding frenzy on a southeastern farm left three cattle dead of what researchers believe was severe blood loss. The scientists from The Ohio State University have reported in the Journal of Medical Entomology on the state’s first known established […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Forest restoration can boost people, nature and climate simultaneously

Forest restoration can benefit humans, boost biodiversity and help tackle climate change simultaneously, new research suggests. Restoring forests is often seen in terms of “trade-offs” — meaning it often focuses on a specific goal such as capturing carbon, nurturing nature or supporting human livelihoods. The new study, by the universities of Exeter and Oxford, found […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Lampreys possess a ‘jaw-dropping’ evolutionary origin

One of just two vertebrates without a jaw, sea lampreys that are wreaking havoc in Midwestern fisheries are simultaneously helping scientists understand the origins of two important stem cells that drove the evolution of vertebrates. Northwestern University biologists have pinpointed when the gene network that regulates these stem cells may have evolved and gained insights […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus Saint-Herblain (France), November 10, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved Ixchiq®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome

Treatment for: WHIM Syndrome X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) –X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the United States Food and Drug […]
Written by
  1. Biology

Enhanced information in national policies can accelerate Africa’s

New analysis of African national adaptation policy documents finds that most fail to provide comprehensive and consistent information. But the authors also uncover compelling examples of robust plans which hold lessons for upcoming climate talks.   New analysis of African national adaptation policy documents finds that most fail to provide comprehensive and consistent information. But […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Access Denied

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.